Kunpeng Lv

797 total citations
19 papers, 484 citations indexed

About

Kunpeng Lv is a scholar working on Immunology, Oncology and Gastroenterology. According to data from OpenAlex, Kunpeng Lv has authored 19 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 12 papers in Oncology and 4 papers in Gastroenterology. Recurrent topics in Kunpeng Lv's work include Cancer Immunotherapy and Biomarkers (11 papers), Immune Cell Function and Interaction (10 papers) and Immune cells in cancer (5 papers). Kunpeng Lv is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Immune Cell Function and Interaction (10 papers) and Immune cells in cancer (5 papers). Kunpeng Lv collaborates with scholars based in China, Japan and India. Kunpeng Lv's co-authors include Chao Lin, Hongyong He, Ruochen Li, Yun Gu, Heng Zhang, Hao Liu, Hanji Fang, Jieti Wang, He Li and Xudong He and has published in prestigious journals such as Nature Communications, Annals of Surgery and British Journal of Cancer.

In The Last Decade

Kunpeng Lv

19 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kunpeng Lv China 14 274 271 142 109 88 19 484
Yifan Cao China 14 249 0.9× 290 1.1× 175 1.2× 136 1.2× 95 1.1× 29 529
Hanne Lind United States 5 152 0.6× 336 1.2× 150 1.1× 128 1.2× 134 1.5× 7 496
Changchang Lu China 9 247 0.9× 260 1.0× 131 0.9× 58 0.5× 74 0.8× 20 448
Kezhuo Yu China 3 306 1.1× 278 1.0× 240 1.7× 80 0.7× 108 1.2× 3 547
Paul-Yang Lin Taiwan 7 159 0.6× 227 0.8× 124 0.9× 74 0.7× 61 0.7× 8 404
Yufei Bo China 4 193 0.7× 195 0.7× 141 1.0× 61 0.6× 76 0.9× 7 397
Mou Peng China 12 144 0.5× 119 0.4× 174 1.2× 72 0.7× 85 1.0× 27 427
Fabio Scirocchi Italy 10 155 0.6× 193 0.7× 130 0.9× 83 0.8× 87 1.0× 15 395
Guodong Deng China 12 122 0.4× 175 0.6× 162 1.1× 73 0.7× 79 0.9× 30 392
Christopher McQuinn United States 3 187 0.7× 337 1.2× 106 0.7× 33 0.3× 62 0.7× 6 439

Countries citing papers authored by Kunpeng Lv

Since Specialization
Citations

This map shows the geographic impact of Kunpeng Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kunpeng Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kunpeng Lv more than expected).

Fields of papers citing papers by Kunpeng Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kunpeng Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kunpeng Lv. The network helps show where Kunpeng Lv may publish in the future.

Co-authorship network of co-authors of Kunpeng Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Kunpeng Lv. A scholar is included among the top collaborators of Kunpeng Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kunpeng Lv. Kunpeng Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Lv, Kunpeng, Mengyao Sun, Hanji Fang, et al.. (2023). Targeting myeloid checkpoint Siglec-10 reactivates antitumor immunity and improves anti-programmed cell death 1 efficacy in gastric cancer. Journal for ImmunoTherapy of Cancer. 11(11). e007669–e007669. 15 indexed citations
2.
Gu, Yun, Jieti Wang, Kunpeng Lv, et al.. (2023). Complement receptor C5aR1 blockade reprograms tumor‐associated macrophages and synergizes with anti‐PD‐1 therapy in gastric cancer. International Journal of Cancer. 153(1). 224–237. 14 indexed citations
3.
Liu, Xin, Kunpeng Lv, Jieti Wang, et al.. (2023). C-type lectin receptor Dectin-1 blockade on tumour-associated macrophages improves anti-PD-1 efficacy in gastric cancer. British Journal of Cancer. 129(4). 721–732. 17 indexed citations
4.
He, Xudong, Yifan Cao, Yun Gu, et al.. (2021). Clinical Outcomes and Immune Metrics in Intratumoral Basophil-Enriched Gastric Cancer Patients. Annals of Surgical Oncology. 28(11). 6439–6450. 20 indexed citations
5.
Fei, Yuchao, Yun Gu, Hanji Fang, et al.. (2021). Intratumoral Foxp3+RORγt+ T cell infiltration determines poor prognosis and immunoevasive contexture in gastric cancer patients. Cancer Immunology Immunotherapy. 71(1). 1–11. 8 indexed citations
6.
Wang, Jieti, Ruochen Li, Yifan Cao, et al.. (2021). Intratumoral CXCR5+CD8+T associates with favorable clinical outcomes and immunogenic contexture in gastric cancer. Nature Communications. 12(1). 3080–3080. 56 indexed citations
7.
He, Xudong, Yun Gu, Yifan Cao, et al.. (2021). Impact of intratumoural CD73 expression on prognosis and therapeutic response in patients with gastric cancer. European Journal of Cancer. 157. 114–123. 20 indexed citations
8.
Chen, Ke, Yun Gu, Yifan Cao, et al.. (2021). TIM3+ cells in gastric cancer: clinical correlates and association with immune context. British Journal of Cancer. 126(1). 100–108. 19 indexed citations
9.
Gu, Yun, Kaifeng Jin, Hanji Fang, et al.. (2021). CD47 expression in gastric cancer clinical correlates and association with macrophage infiltration. Cancer Immunology Immunotherapy. 70(7). 1831–1840. 51 indexed citations
10.
Jin, Kaifeng, Yifan Cao, Yun Gu, et al.. (2021). Poor clinical outcomes and immunoevasive contexture in CXCL13+CD8+ T cells enriched gastric cancer patients. OncoImmunology. 10(1). 1915560–1915560. 25 indexed citations
11.
Li, Ruochen, Hao Liu, Jieti Wang, et al.. (2020). Identification and validation of an immunogenic subtype of gastric cancer with abundant intratumoural CD103+CD8+ T cells conferring favourable prognosis. British Journal of Cancer. 122(10). 1525–1534. 36 indexed citations
12.
Fang, Hanji, Yun Gu, Yuchao Fei, et al.. (2020). Intratumoral interleukin-9 delineates a distinct immunogenic class of gastric cancer patients with better prognosis and adjuvant chemotherapeutic response. OncoImmunology. 9(1). 1856468–1856468. 13 indexed citations
13.
Lv, Kunpeng, Ruochen Li, Yun Gu, et al.. (2020). Lymphocyte‐activation gene 3 expression associates with poor prognosis and immunoevasive contexture in Epstein‐Barr virus‐positive and MLH1‐defective gastric cancer patients. International Journal of Cancer. 148(3). 759–768. 19 indexed citations
14.
Gu, Yun, Yifan Chen, Kaifeng Jin, et al.. (2020). Intratumoral CD103 + CD4 + T cell infiltration defines immunoevasive contexture and poor clinical outcomes in gastric cancer patients. OncoImmunology. 9(1). 1844402–1844402. 17 indexed citations
15.
Li, Ruochen, Yifan Cao, Yun Gu, et al.. (2020). Poor Clinical Outcomes and Immunoevasive Contexture in Intratumoral IL-10-Producing Macrophages Enriched Gastric Cancer Patients. Annals of Surgery. 275(4). e626–e635. 120 indexed citations
16.
Wang, Lei, Jiang Long, Huan Chen, et al.. (2020). Manipulation of focal Wnt activity via synthetic cells in a double‐humanized zebrafish model of tumorigenesis. International Journal of Cancer. 148(11). 2815–2824. 5 indexed citations
17.
Liu, Xin, Yifan Cao, Kunpeng Lv, et al.. (2020). Tumor-infiltrating podoplanin + cells in gastric cancer: clinical outcomes and association with immune contexture. OncoImmunology. 9(1). 1845038–1845038. 10 indexed citations
18.
Wang, Lei, Huan Chen, Fei Fei, et al.. (2019). Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment. Journal of Visualized Experiments. 15 indexed citations
19.
Wang, Lei, Huan Chen, Fei Fei, et al.. (2019). Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment. Journal of Visualized Experiments. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yifan Cao Breakdown of academic impact, for papers by Hanne Lind Breakdown of academic impact, for papers by Changchang Lu Breakdown of academic impact, for papers by Kezhuo Yu Breakdown of academic impact, for papers by Paul-Yang Lin Breakdown of academic impact, for papers by Yufei Bo Breakdown of academic impact, for papers by Mou Peng Breakdown of academic impact, for papers by Fabio Scirocchi Breakdown of academic impact, for papers by Guodong Deng Breakdown of academic impact, for papers by Christopher McQuinn
Rankless by CCL
2026